<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cappelli, Laura C.</style></author><author><style face="normal" font="default" size="100%">Fitzpatrick, Rebecca</style></author><author><style face="normal" font="default" size="100%">Bingham, Clifton O.</style></author><author><style face="normal" font="default" size="100%">Shah, Ami A.</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Dr. Cappelli et al reply</style></title><secondary-title><style face="normal" font="default" size="100%">The Journal of Rheumatology</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2026</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2026-07-15 04:00:26</style></date></pub-dates></dates><elocation-id><style  face="normal" font="default" size="100%">jrheum.2026-0554</style></elocation-id><doi><style  face="normal" font="default" size="100%">10.3899/jrheum.2026-0554</style></doi><volume><style face="normal" font="default" size="100%"></style></volume><issue><style face="normal" font="default" size="100%"></style></issue><abstract><style  face="normal" font="default" size="100%">We thank the authors1 for their interest in our study2 and for their comments. Our study was designed to test the hypothesis that osteoarthritis (OA) at distant joints could predispose patients to develop inflammatory arthritis (IA) from immune checkpoint inhibitor therapy (ICI).</style></abstract></record></records></xml>